Queensland research is providing new hope to immunocompromised people who are vulnerable to COVID-19. Scientists from QIMR Berghofer have discovered promising evidence that T cell immunotherapy could help them to fight against ...
Mar 22, 2022
0
20
Results of a study presented at the Society of Interventional Radiology's 37th Annual Scientific Meeting in San Francisco, Calif., signal a light at the end of the tunnel for individuals with inoperable locally advanced pancreatic ...
Mar 26, 2012
0
1
A new study at the University of Wisconsin-Madison has linked two seemingly unrelated cancer treatments that are both now being tested in clinical trials.
Jul 13, 2015
0
26
Scientists have identified a collection of biomarkers that together signal that a person's cancer treatment may be harming their heart. After further validation, the biomarkers could eventually allow doctors to assess cardiovascular ...
Apr 27, 2020
0
2
(HealthDay)—U.S. Food and Drug Administration approval for the anti-cancer drug Nexavar (sorafenib) has been expanded to include late-stage differentiated thyroid cancer, the most common type of thyroid cancer.
Nov 24, 2013
0
0
Researchers from the University of Southampton have identified why some people may become resistant to monoclonal antibodies, a common type of immunotherapy used in lymphoma treatment.
Jul 14, 2017
0
1
Prostate cancer that has spread to the bones can cause pain and fractures.
Aug 23, 2013
0
1
Researchers from A*STAR's Institute of Bioengineering and Bioimaging (IBB), in collaboration with Changi General Hospital (CGH) and Lucence, a local biomedical start-up, conducted the first local prospective study which demonstrated ...
Jul 29, 2022
0
1
After an intensive three-year hunt through the genome, medical researchers have pinpointed mutations that leads to drug resistance and relapse in the most common type of childhood cancer—the first time anyone has linked ...
Feb 3, 2013
0
0
The lymphatic system has long been considered mysterious.
Aug 3, 2023
0
6
